annual operating expenses:
$361.95M+$106.17M(+41.51%)Summary
- As of today (May 21, 2025), ANIP annual total operating expenses is $361.95 million, with the most recent change of +$106.17 million (+41.51%) on December 31, 2024.
- During the last 3 years, ANIP annual operating expenses has risen by +$218.25 million (+151.89%).
- ANIP annual operating expenses is now at all-time high.
Performance
ANIP Operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating expenses:
$109.98M+$1.02M(+0.93%)Summary
- As of today (May 21, 2025), ANIP quarterly total operating expenses is $109.98 million, with the most recent change of +$1.02 million (+0.93%) on March 31, 2025.
- Over the past year, ANIP quarterly operating expenses has increased by +$36.77 million (+50.21%).
- ANIP quarterly operating expenses is now at all-time high.
Performance
ANIP quarterly operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
ANIP Operating expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +41.5% | +50.2% |
| 3 y3 years | +151.9% | +126.1% |
| 5 y5 years | +185.1% | +207.1% |
ANIP Operating expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +151.9% | at high | +126.1% |
| 5 y | 5-year | at high | +185.1% | at high | +265.9% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
ANIP Operating expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $109.98M(+0.9%) |
| Dec 2024 | $361.95M(+41.5%) | $108.97M(+3.8%) |
| Sep 2024 | - | $104.95M(+40.3%) |
| Jun 2024 | - | $74.81M(+2.2%) |
| Mar 2024 | - | $73.22M(+5.3%) |
| Dec 2023 | $255.77M(+25.8%) | $69.52M(+1.7%) |
| Sep 2023 | - | $68.33M(+12.3%) |
| Jun 2023 | - | $60.82M(+6.5%) |
| Mar 2023 | - | $57.09M(+7.9%) |
| Dec 2022 | $203.33M(+41.5%) | $52.89M(+1.9%) |
| Sep 2022 | - | $51.91M(+4.0%) |
| Jun 2022 | - | $49.89M(+2.5%) |
| Mar 2022 | - | $48.65M(+2.4%) |
| Dec 2021 | $143.69M(+5.0%) | $47.53M(+52.3%) |
| Sep 2021 | - | $31.21M(-6.7%) |
| Jun 2021 | - | $33.46M(+6.3%) |
| Mar 2021 | - | $31.49M(-1.4%) |
| Dec 2020 | $136.89M(+7.8%) | $31.93M(+6.2%) |
| Sep 2020 | - | $30.06M(-23.1%) |
| Jun 2020 | - | $39.08M(+9.1%) |
| Mar 2020 | - | $35.81M(+3.0%) |
| Dec 2019 | $126.97M(+36.2%) | $34.77M(+19.9%) |
| Sep 2019 | - | $29.01M(-1.4%) |
| Jun 2019 | - | $29.43M(-12.8%) |
| Mar 2019 | - | $33.76M(+32.2%) |
| Dec 2018 | $93.19M(+35.9%) | $25.54M(+2.2%) |
| Sep 2018 | - | $24.98M(+6.7%) |
| Jun 2018 | - | $23.41M(+21.6%) |
| Mar 2018 | - | $19.25M(+3.7%) |
| Dec 2017 | $68.58M(+29.2%) | $18.56M(+4.5%) |
| Sep 2017 | - | $17.75M(+6.6%) |
| Jun 2017 | - | $16.65M(+6.6%) |
| Mar 2017 | - | $15.62M(+17.3%) |
| Dec 2016 | $53.08M(+71.6%) | $13.32M(-4.4%) |
| Sep 2016 | - | $13.94M(-2.9%) |
| Jun 2016 | - | $14.35M(+25.0%) |
| Mar 2016 | - | $11.48M(+39.5%) |
| Dec 2015 | $30.93M(+26.3%) | $8.23M(-0.4%) |
| Sep 2015 | - | $8.26M(+3.8%) |
| Jun 2015 | - | $7.96M(+22.8%) |
| Mar 2015 | - | $6.48M(-1.7%) |
| Dec 2014 | $24.49M(+27.5%) | $6.59M(+7.6%) |
| Sep 2014 | - | $6.13M(-12.3%) |
| Jun 2014 | - | $6.99M(+46.2%) |
| Mar 2014 | - | $4.78M(+9.0%) |
| Dec 2013 | $19.21M(-24.6%) | $4.39M(+1.7%) |
| Sep 2013 | - | $4.32M(-44.4%) |
| Jun 2013 | - | $7.76M(+151.2%) |
| Mar 2013 | - | $3.09M(-44.9%) |
| Dec 2012 | $25.47M | $5.60M(+2.9%) |
| Sep 2012 | - | $5.45M(-26.2%) |
| Jun 2012 | - | $7.38M(+4.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $7.05M(-17.2%) |
| Dec 2011 | $51.36M(+11.5%) | $8.51M(-35.6%) |
| Sep 2011 | - | $13.21M(+0.5%) |
| Jun 2011 | - | $13.15M(-20.3%) |
| Mar 2011 | - | $16.50M(+24.0%) |
| Dec 2010 | $46.08M(+17.0%) | $13.31M(+17.9%) |
| Sep 2010 | - | $11.29M(+10.3%) |
| Jun 2010 | - | $10.24M(-8.9%) |
| Mar 2010 | - | $11.24M(-56.1%) |
| Dec 2009 | $39.38M(+80.7%) | $25.61M(+421.5%) |
| Sep 2009 | - | $4.91M(+3.7%) |
| Jun 2009 | - | $4.74M(+14.7%) |
| Mar 2009 | - | $4.13M(-24.5%) |
| Dec 2008 | $21.79M(+137.6%) | $5.47M(-19.3%) |
| Sep 2008 | - | $6.77M(+22.3%) |
| Jun 2008 | - | $5.54M(+38.0%) |
| Mar 2008 | - | $4.01M(+71.4%) |
| Dec 2007 | $9.17M(-16.6%) | $2.34M(+6.9%) |
| Sep 2007 | - | $2.19M(-18.9%) |
| Jun 2007 | - | $2.70M(+39.2%) |
| Mar 2007 | - | $1.94M(-52.8%) |
| Dec 2006 | $11.00M(+15.0%) | $4.11M(+307.9%) |
| Sep 2006 | - | $1.01M(-59.2%) |
| Jun 2006 | - | $2.47M(-27.5%) |
| Mar 2006 | - | $3.41M(+80.4%) |
| Dec 2005 | $9.56M(-22.6%) | $1.89M(-7.6%) |
| Sep 2005 | - | $2.04M(-25.1%) |
| Jun 2005 | - | $2.73M(-5.8%) |
| Mar 2005 | - | $2.90M(-32.1%) |
| Dec 2004 | $12.34M(+102.0%) | $4.26M(+43.8%) |
| Sep 2004 | - | $2.96M(+12.5%) |
| Jun 2004 | - | $2.63M(+6.2%) |
| Mar 2004 | - | $2.48M(+46.7%) |
| Dec 2003 | $6.11M(-8.0%) | $1.69M(+15.4%) |
| Sep 2003 | - | $1.46M(-10.0%) |
| Jun 2003 | - | $1.63M(+22.5%) |
| Mar 2003 | - | $1.33M(-41.0%) |
| Dec 2002 | $6.64M(+46.6%) | $2.25M(+27.7%) |
| Sep 2002 | - | $1.76M(+17.4%) |
| Jun 2002 | - | $1.50M(+36.2%) |
| Mar 2002 | - | $1.10M(-23.4%) |
| Dec 2001 | $4.53M(+23.7%) | $1.44M(-1.4%) |
| Sep 2001 | - | $1.46M(+60.6%) |
| Jun 2001 | - | $909.80K(+26.0%) |
| Mar 2001 | - | $722.00K(-25.7%) |
| Dec 2000 | $3.66M(+128.4%) | $972.10K(+42.8%) |
| Sep 2000 | - | $680.90K(-54.5%) |
| Jun 2000 | - | $1.50M(+189.8%) |
| Mar 2000 | - | $516.20K(+58.2%) |
| Dec 1999 | $1.60M(-42.3%) | - |
| Jun 1999 | - | $326.20K |
| Dec 1998 | $2.78M | - |
FAQ
- What is ANI Pharmaceuticals annual total operating expenses?
- What is the all time high annual operating expenses for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals annual operating expenses year-on-year change?
- What is ANI Pharmaceuticals quarterly total operating expenses?
- What is the all time high quarterly operating expenses for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals quarterly operating expenses year-on-year change?
What is ANI Pharmaceuticals annual total operating expenses?
The current annual operating expenses of ANIP is $361.95M
What is the all time high annual operating expenses for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high annual total operating expenses is $361.95M
What is ANI Pharmaceuticals annual operating expenses year-on-year change?
Over the past year, ANIP annual total operating expenses has changed by +$106.17M (+41.51%)
What is ANI Pharmaceuticals quarterly total operating expenses?
The current quarterly operating expenses of ANIP is $109.98M
What is the all time high quarterly operating expenses for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high quarterly total operating expenses is $109.98M
What is ANI Pharmaceuticals quarterly operating expenses year-on-year change?
Over the past year, ANIP quarterly total operating expenses has changed by +$36.77M (+50.21%)